Literature DB >> 19252031

Aminoglycoside ototoxicity susceptibility in cystic fibrosis.

S A Mulrennan, J Helm, R Bright Thomas, M Dodd, A Jones, K Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19252031     DOI： 10.1136/thx.2008.103010

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  Minimizing the toxicity of aminoglycosides in cystic fibrosis.

Authors:  Alan R Smyth
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

Review 2.  Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.

Authors:  Geraint B Rogers; Lucas R Hoffman; Marvin Whiteley; Thomas W V Daniels; Mary P Carroll; Kenneth D Bruce
Journal:  Trends Microbiol       Date:  2010-06-01       Impact factor: 17.079

3.  Effects of 'Perinatal Risk Factors Associated with Hearing Loss' on Auditory Outcomes in Cochlear Implant Recipient Children.

Authors:  Vishal Gaurav; Shalabh Sharma; Satinder Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-08-12

Review 4.  Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis.

Authors:  John Lam; Steven Vaughan; Michael D Parkins
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2013-11-13

Review 5.  Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review.

Authors:  Debora T M Caumo; Lúcia B Geyer; Adriane R Teixeira; Sérgio S M Barreto
Journal:  Braz J Otorhinolaryngol       Date:  2016-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.